Cetuximab
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9794 publications
FOLFOX-based transarterial infusion chemotherapy for unresectable colorectal cancer: protocol of an open-label, multicentre, randomised, controlled, phase II trial.
Journal: BMJ open
Published: September 12, 2026
Three Cases of Encorafenib Treatment for Recurrent BRAF-Mutated Colorectal Cancer
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: September 11, 2026
Extensive Subcutaneous Hematoma in a Patient Receiving Nigella sativa Oil, Dual Antiplatelet Therapy, and Oxaliplatin-Based Chemotherapy: A Case Report.
Journal: Hospital pharmacy
Published: September 02, 2026
Predictive biomarkers for cetuximab-based rechallenge therapy in metastatic colorectal cancer: a pooled analysis of the CAVE and CAVE-2 GOIM studies.
Journal: ESMO gastrointestinal oncology
Published: August 28, 2026
Long-Term Survival Outcomes of Modified-FOLFOXIRI Plus Cetuximab Versus Bevacizumab in RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Final Analysis of the DEEPER Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 27, 2026
FOLFOX Plus Bevacizumab Rechallenge Versus Regorafenib as Third-Line Treatment in Metastatic Colorectal Cancer: The Role of the Oxaliplatin-Free Interval.
Journal: Cancers
Published: August 25, 2026
Ras homolog family member A expression is associated with reduced cetuximab sensitivity in head and neck squamous cell carcinoma.
Journal: The Journal of international medical research
Published: August 24, 2026
Experimental and computational analyses of altered cetuximab binding induced by EGFR mutations
Journal: Sheng wu gong cheng xue bao = Chinese journal of biotechnology
Published: August 24, 2026
Circulating tumor DNA tumor fraction as a biomarker in refractory metastatic colorectal cancer: findings from the CAVE-2 GOIM trial.
Journal: The journal of liquid biopsy
Published: August 20, 2026
Analysis of antiviral effects of anti-EGFR DNA aptamers against African swine fever virus in Vero cells.
Journal: Microbial pathogenesis
Published: August 17, 2026
Last Updated: 11/08/2026